New hope for kids with rare leukemia as experimental treatment begins testing
NCT ID NCT05849662
First seen Apr 17, 2026 · Last updated Apr 17, 2026
Summary
This study is testing whether combining two drugs, trametinib and azacitidine, is safe and effective for children with juvenile myelomonocytic leukemia (JMML), a rare and aggressive blood cancer. Children with lower-risk JMML will receive just the two drugs, while those with higher-risk disease will also receive additional chemotherapy. The trial aims to find better treatment options for this serious childhood cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
C.S. Mott Children's Hospital
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
-
Children's Hospital Los Angeles
RECRUITINGLos Angeles, California, 900027, United States
Contact
-
Children's Hospital of Atlanta
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
Children's Hospital of Colorado
RECRUITINGDenver, Colorado, 80045, United States
Contact
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
-
Children's Mercy Hospital
RECRUITINGKansas City, Missouri, 64108, United States
Contact
-
Children's National Medical Center
RECRUITINGWashington D.C., District of Columbia, 20010, United States
Contact
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
-
Indiana University/Riley Hospital for Children
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact
-
Lurie Children's Hospital of Chicago
RECRUITINGChicago, Illinois, 60611, United States
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
-
Oregon Health & Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact
-
Phoenix Children's Hospital
RECRUITINGPhoenix, Arizona, 85016, United States
Contact
-
Primary Children's Hospital
RECRUITINGSalt Lake City, Utah, 84113, United States
Contact
-
Seattle Children's Hospital
RECRUITINGSeattle, Washington, 98105, United States
Contact
-
Sidney Kimmel Cancer Center at Johns Hopkins
RECRUITINGBaltimore, Maryland, 21231, United States
Contact
-
St. Jude Children's Research Hospital Memphis
RECRUITINGMemphis, Tennessee, 38105, United States
Contact
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94158, United States
Contact
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact
Conditions
Explore the condition pages connected to this study.